Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
cbdMD, Inc. (YCBD)
USD0.68
+0.02 (+3.42%)
US AMEX Healthcare Drug Manufacturers - Specialty & Generic
Address
8845 Red Oak Boulevard 28217
Charlotte, NC, US
Charlotte, NC, US
CEO
T. Ronan Kennedy
Website
cbdmd.com
IPO
2017-11-17
CIK 1644903 ISIN US12482W4087
Also trades on
New York Stock Exchange American · YCBD (USD)
New York Stock Exchange Arca · YCBD-PA (USD)
Description
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.68
+0.02 (+3.42%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
2.13
Float Shares
10.20M
Free Float %
97.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.82% | -5.79% | +11.30% | +15.56% | +26.21% | -39.98% | -17.32% | -95.03% | -99.92% | -99.96% | -99.96% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
0.68
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-19.86
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%-1.5% Q1'26: +118,652.4% (vs Q1'25)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+39.1% ★ Q1'26: +57.9% (vs Q1'25)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-13.1% Q1'26: -27.3% (vs Q1'25)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-11.3% Q1'26: +0.0% (vs Q1'25)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%-0.3% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%-6.7% ★ Q1'26: +34.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-2,122.47× Q1'26: -0.13× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 1 Rev. Ana. 1 EPS Ana. |
Sep 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
23.65M
est: 25.01M (-5.4%)
|
41.88M
est: 41.39M (+1.2%)
|
44.48M
est: 45.94M (-3.2%)
|
35.40M
est: 40.80M (-13.2%)
|
24.16M
est: 24.58M (-1.7%)
|
19.48M
est: 19.73M (-1.3%)
|
19.19M
est: 19.17M (+0.1%)
|
21.20M
21.20M – 21.20M
+10.6% YoY
|
22.69M
22.69M – 22.69M
+7.0% YoY
|
| EBITDA |
-14.07M
est: -11.20M (-25.6%)
|
-15.68M
est: -18.54M (+15.4%)
|
-17.36M
est: -20.58M (+15.6%)
|
-14.34M
est: -18.28M (+21.5%)
|
-6.34M
est: -4.11M (-54.1%)
|
-1.37M
est: 6.87M (-119.9%)
|
-366.7K
est: 6.67M (-105.5%)
|
7.38M
7.38M – 7.38M
+10.6% YoY
|
7.90M
7.90M – 7.90M
+7.0% YoY
|
| EBIT |
-14.36M
est: -13.18M (-9.0%)
|
-17.58M
est: -21.81M (+19.4%)
|
-19.62M
est: -24.21M (+19.0%)
|
-17.31M
est: -21.50M (+19.5%)
|
-9.27M
est: -5.83M (-59.0%)
|
-3.19M
est: 4.74M (-167.2%)
|
-2.16M
est: 4.61M (-146.9%)
|
5.10M
5.10M – 5.10M
+10.6% YoY
|
5.45M
5.45M – 5.45M
+7.0% YoY
|
| Net Income |
-50.43M
est: -3.95B (+98.7%)
|
12.60M
est: -46.58M (+127.1%)
|
-23.39M
est: -574.43M (+95.9%)
|
-70.08M
est: -791.78M (+91.1%)
|
-22.94M
est: -25.66M (+10.6%)
|
-3.70M
est: -84.64M (+95.6%)
|
-2.04M
est: -4.34M (+53.0%)
|
-563.2K
-563.2K – -563.2K
+87.0% YoY
|
-281.6K
-281.6K – -281.6K
+50.0% YoY
|
| SGA |
28.88M
est: 20.01M (+44.3%)
|
43.95M
est: 33.11M (+32.8%)
|
48.58M
est: 36.75M (+32.2%)
|
37.81M
est: 32.63M (+15.9%)
|
22.31M
est: 20.48M (+8.9%)
|
14.04M
est: 17.69M (-20.6%)
|
13.00M
est: 17.19M (-24.3%)
|
19.01M
19.01M – 19.01M
+10.6% YoY
|
20.34M
20.34M – 20.34M
+7.0% YoY
|
| EPS |
-114.29
est: -916.80 (+87.5%)
|
12.47
est: -10.80 (+215.5%)
|
-19.16
est: -133.20 (+85.6%)
|
-55.80
est: -183.60 (+69.6%)
|
-13.32
est: -6.38 (-108.8%)
|
-1.79
est: -21.04 (+91.5%)
|
-1.09
est: -1.08 (-0.9%)
|
-0.14
-0.14 – -0.14
+87.0% YoY
|
-0.07
-0.07 – -0.07
+50.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | C+ | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-806.47M
OE per share TTM
-79.82
Owner's Yield
-9,529.98%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
16.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
11
Total invested
280.1K
Insider transactions (90d)
0
Beneficial owners (>5%)
8
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Worldwide Media Services Group, Inc. | 4.24M | 6.50% | 4.24M | — | — | — | HC, OO | Delaware, United States | 2023-03-03 | ↗ |
| 2 | a360 Media, LLC | 4.24M | 6.50% | 4.24M | — | — | — | OO | Delaware, United States | 2023-03-03 | ↗ |
| 3 | OFFICE, LLC | 1.52M | 6.00% | 1.52M | — | 1.52M | — | OO | North Carolina | 2019-05-01 | ↗ |
| 4 | Trustee | 1.03M | 13.30% | — | 1.03M | — | — | IN | United States | 2017-11-16 | ↗ |
| 5 | u/t/d December 10, 1993 | 1.03M | 13.30% | 1.03M | — | 1.03M | — | OO | United States | 2017-11-16 | ↗ |
| 6 | Erik Sterling | — | 0.00% | — | — | — | — | IN | United States | 2019-04-17 | ↗ |
| 7 | Jason Winters | — | 0.00% | — | — | — | — | IN | United States | 2019-04-17 | ↗ |
| 8 | Sterling Winters Living Trust u/t/d December 10, 1993 | — | 0.00% | — | — | — | — | OO | United States | 2019-04-17 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
11
-13 vs prev Q
New positions
4
Closed positions
17
Increased
7
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | WORTH VENTURE PARTNERS, LLC | 268.3K +268.3K (+100.0%) | 362.2K +362.2K (+100.0%) | 2.98% +2.980 pp | 2.62% +2.623 pp | USD1.35 +0.0% | 1 qtrs NEW |
| 2 | CSS LLC/IL | 141.6K -1.0K (-0.7%) | 191.2K +18.6K (+10.8%) | 1.57% -1.973 pp | 0.01% +0.001 pp | USD0.89 +51.7% | 3 qtrs — |
| 3 | VANGUARD GROUP INC | 98.2K +46.6K (+90.5%) | 132.6K +70.2K (+112.5%) | 1.09% -0.191 pp | 0.00% +0.000 pp | USD1.28 +5.5% | 2 qtrs — |
| 4 | CHAPIN DAVIS, INC. | 81.3K -40.3K (-33.2%) | 109.7K -37.4K (-25.4%) | 0.90% -2.119 pp | 0.03% -0.010 pp | USD0.90 +50.0% | 3 qtrs — |
| 5 | ALESCO ADVISORS LLC | 68.5K +— (+0.0%) | 92.5K +9.6K (+11.6%) | 0.76% -0.942 pp | 0.00% +0.000 pp | USD0.89 +51.7% | 3 qtrs — |
| 6 | JANE STREET GROUP, LLC | 51.1K +51.1K (+100.0%) | 69.0K +69.0K (+100.0%) | 0.57% +0.568 pp | 0.00% +0.000 pp | USD1.35 +0.0% | 3 qtrs — |
| 7 | CITIGROUP INC | 31.4K +31.4K (+100.0%) | 42.4K +42.4K (+100.0%) | 0.35% +0.349 pp | 0.00% +0.000 pp | USD1.35 +0.0% | 1 qtrs NEW |
| 8 | COMMONWEALTH EQUITY SERVICES, LLC | 16.3K +— (+0.0%) | 21.9K +1.9K (+9.7%) | 0.18% -0.224 pp | 0.00% +0.000 pp | USD0.89 +51.7% | 3 qtrs — |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 12.0K +12.0K (+100.0%) | 16.2K +16.2K (+100.0%) | 0.13% +0.133 pp | 0.00% +0.000 pp | USD1.35 +0.0% | 1 qtrs NEW |
| 10 | STONEX GROUP INC. | 11.4K +11.4K (+100.0%) | 15.4K +15.4K (+100.0%) | 0.13% +0.126 pp | 0.00% +0.001 pp | USD1.35 +0.0% | 1 qtrs NEW |
| 11 | UBS GROUP AG | 10.2K +10.1K (+101,410.0%) | 13.7K +13.7K (+114,100.0%) | 0.11% +0.113 pp | 0.00% +0.000 pp | USD1.35 +0.0% | 3 qtrs — |
| 12 | HARBOUR INVESTMENTS, INC. | 5.2K +— (+0.0%) | 7.0K +728.0 (+11.6%) | 0.06% -0.072 pp | 0.00% +0.000 pp | USD0.89 +51.7% | 3 qtrs — |
| 13 | CAMELOT PORTFOLIOS, LLC | 3.3K +3.3K (+100.0%) | 4.4K +4.4K (+100.0%) | 0.04% +0.036 pp | 0.00% +0.003 pp | USD1.35 +0.0% | 1 qtrs NEW |
| 14 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.9K +1.2K (+163.3%) | 2.6K +1.7K (+193.6%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD1.28 +5.5% | 3 qtrs — |
| 15 | MORGAN STANLEY | 1.1K +— (+0.0%) | 1.5K +160.0 (+11.6%) | 0.01% -0.016 pp | 0.00% +0.000 pp | USD0.89 +51.7% | 3 qtrs — |
| 16 | BLACKROCK, INC. | 1.1K +— (+0.0%) | 1.5K +151.0 (+11.6%) | 0.01% -0.015 pp | 0.00% +0.000 pp | USD0.89 +51.7% | 3 qtrs — |
| 17 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 100.00 +100.0 (+100.0%) | 135.00 +135.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD1.35 +0.0% | 1 qtrs NEW |
| 18 | BANK OF AMERICA CORP /DE/ | 80.00 +5.0 (+6.7%) | 108.00 +18.0 (+20.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD0.93 +45.2% | 3 qtrs — |
| 19 | ADVISOR GROUP HOLDINGS, INC. | 55.00 +41.0 (+292.9%) | 73.00 +63.0 (+630.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.22 +10.7% | 3 qtrs — |
| 20 | GOLDEN STATE WEALTH MANAGEMENT, LLC | 4.00 +— (+0.0%) | 4.00 +— (+0.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.75 +80.0% | 3 qtrs — |
| 21 | FARTHER FINANCE ADVISORS, LLC | 2.00 -1.0 (-33.3%) | 3.00 -1.0 (-25.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.50 +170.0% | 3 qtrs — |
| 22 | GROUP ONE TRADING, L.P. | 2.00 +— (+0.0%) | 3.00 +1.0 (+50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.50 +170.0% | 3 qtrs — |
| 23 | ROTHSCHILD INVESTMENT LLC | 1.00 +— (+0.0%) | 1.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs — |
| 24 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 1.00 +— (+0.0%) | 1.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +35.0% | 2 qtrs — |
| 25 | ADVISORY SERVICES NETWORK, LLC | — -2.0 (-100.0%) | — -2.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 26 | SASSICAIA CAPITAL ADVISERS LLC | — -12.0K (-100.0%) | — -14.5K (-100.0%) | 0.00% -0.298 pp | 0.00% -0.007 pp | USD— | 2 qtrs SOLD |
| 27 | SCIENTECH RESEARCH LLC | — -15.4K (-100.0%) | — -18.6K (-100.0%) | 0.00% -0.383 pp | 0.00% -0.007 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 92.6K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
6
Sells
0
Shares acquired
9.4K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+9,432
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-14 | Swift Sibyl Nichole | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 4,145 | D | ↗ |
| 2026-04-14 | Stephen Scott G. | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 4,412 | D | ↗ |
| 2026-04-14 | Sellers Bakari T. | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 4,324 | D | ↗ |
| 2026-04-14 | Roe Kevin Charles | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 26,707 | D | ↗ |
| 2026-04-14 | Raines William F III | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 13,676 | D | ↗ |
| 2026-04-14 | Porter Jeffrey H | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 3,144 | D | ↗ |
| 2025-12-17 | Crosnoe Clark R. | 10% Owner | S-Sale | D | Common Stock | 461,725 | 2.31 | 1.07M | 361,400 | I | ↗ |
| 2025-11-28 | Kennedy Thomas Ronan | Director / Officer | A-Award | A | Common Stock | 445,000 | 0.00 | — | 513,722 | D | ↗ |
| 2025-05-16 | Swift Sibyl Nichole | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 2,573 | D | ↗ |
| 2025-05-16 | Stephen Scott G. | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 2,840 | D | ↗ |
| 2025-05-16 | Sellers Bakari T. | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 2,752 | D | ↗ |
| 2025-05-16 | Roe Kevin Charles | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 25,135 | D | ↗ |
| 2025-05-16 | Raines William F III | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 12,104 | D | ↗ |
| 2025-05-16 | Porter Jeffrey H | Director | A-Award | A | Common Stock | 1,572 | 0.00 | — | 1,572 | D | ↗ |
| 2025-05-06 | Roe Kevin Charles | Director | C-Conversion | D | 8% Series A Cumulative Convertible Preferred Stock | 14,500 | 0.00 | — | 0 | D | ↗ |
| 2025-05-06 | Porter Jeffrey H | Director | C-Conversion | A | Common Stock | 41,275 | 0.00 | — | 41,275 | I | ↗ |
| 2025-05-06 | Kennedy Thomas Ronan | Director / Officer | C-Conversion | D | 8% Series A Cumulative Convertible Preferred Stock | 41,765 | 0.00 | — | 0 | D | ↗ |
| 2025-05-06 | Crosnoe Clark R. | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 36,976 | I | ↗ |
| 2025-04-10 | Roe Kevin Charles | Director | — | — | 8% Series A Cumulative Convertible Preferred Stock | 537 | 270.00 | 145.0K | 0 | D | ↗ |
| 2025-04-10 | Porter Jeffrey H | Director | — | — | 8% Series A Cumulative Convertible Preferred Stock | 74 | 270.00 | 20.0K | 0 | I | ↗ |
| 2024-09-26 | Kennedy Thomas Ronan | Officer | P-Purchase | A | 8% Series A Cumulative Convertible Preferred Stock | 1,000 | 270.00 | 270.0K | 41,765 | I | ↗ |
| 2024-09-23 | Kennedy Thomas Ronan | Officer | P-Purchase | A | 8% Series A Cumulative Convertible Preferred Stock | 38,465 | 270.00 | 10.39M | 40,765 | I | ↗ |
| 2024-08-23 | Raines William F III | Director | A-Award | A | Common Stock | 75,000 | 0.00 | — | 84,256 | — | ↗ |
| 2024-03-29 | Whitford Bradley Nelson | Officer | — | D | Common Stock | 0 | 0.00 | — | 445 | — | ↗ |
| 2024-03-29 | Swift Sibyl Nichole | Director | A-Award | A | Stock Options (Right to Buy) | 2,000 | 0.93 | 1.9K | 2,000 | — | ↗ |
| 2024-03-29 | Stephen Scott G. | Director | A-Award | A | Stock Options (Right to Buy) | 2,000 | 0.93 | 1.9K | 2,000 | — | ↗ |
| 2024-03-29 | Sellers Bakari T. | Director | A-Award | A | Stock Options (Right to Buy) | 2,000 | 0.93 | 1.9K | 2,000 | — | ↗ |
| 2024-03-29 | Raines William F III | Director | A-Award | A | Stock Options (Right to Buy) | 2,000 | 0.93 | 1.9K | 2,000 | — | ↗ |
| 2024-01-11 | Coffman Raymond Scott | 10% Owner | A-Award | A | Common Stock | 13,011 | 0.00 | — | 387,695 | — | ↗ |
| 2023-05-03 | Kennedy Thomas Ronan | Officer | P-Purchase | D | Common Stock | 5,000 | 2.10 | 10.5K | 6,462 | — | ↗ |
| 2023-02-17 | Swift Sibyl Nichole | Director | A-Award | A | Stock Options (Right to Buy) | 30,000 | 0.28 | 8.4K | 30,000 | — | ↗ |
| 2023-02-17 | Stephen Scott G. | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 56,052 | — | ↗ |
| 2023-02-17 | Sellers Bakari T. | Director | A-Award | A | Stock Options (Right to Buy) | 30,000 | 0.28 | 8.4K | 30,000 | — | ↗ |
| 2023-02-17 | Raines William F III | Director | A-Award | A | Stock Options (Right to Buy) | 30,000 | 0.28 | 8.4K | 30,000 | — | ↗ |
| 2023-01-09 | Whitford Bradley Nelson | Officer | — | D | Stock Options (Right to Buy) | 334 | 10.53 | 3.5K | 0 | — | ↗ |
| 2022-08-09 | Swift Sibyl Nichole | Director | — | D | Common Stock | 0 | 0.00 | — | 5,250 | — | ↗ |
| 2022-08-09 | Coffman Raymond Scott | Director | A-Award | A | Common Stock | 226,840 | 0.00 | — | 16,860,746 | — | ↗ |
| 2022-05-31 | Wiesehan John J III | Officer | — | D | Stock Option (Right to Buy) | 50,000 | 3.25 | 162.5K | 0 | — | ↗ |
| 2022-05-17 | Sumichrast Martin A. | Director | A-Award | A | Common Stock | 41,299 | 0.00 | — | 1,894,533 | — | ↗ |
| 2022-05-17 | Coffman Raymond Scott | Director | A-Award | A | Common stock | 301,253 | 0.00 | — | 16,591,906 | — | ↗ |
| 2022-05-16 | MacDermott Kevin | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,000 | — | ↗ |
| 2022-03-11 | Stephen Scott G. | Director | A-Award | A | Stock Options (Right to Buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-03-11 | Sellers Bakari T. | Director | A-Award | A | Stock Options (Right to Buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-03-11 | Raines William F III | Director | A-Award | A | Common Stock | 5,000 | 0.00 | — | 11,342 | — | ↗ |
| 2022-03-11 | Ghiloni Peter J. | Director | A-Award | A | Stock Options (Right to Buy) | 30,000 | 0.82 | 24.5K | 30,000 | — | ↗ |
| 2022-03-01 | Swift Sibyl Nichole | Director | — | D | Stock Options (Right to Buy) | 15,000 | 1.00 | 15.0K | 0 | — | ↗ |
| 2022-02-28 | Sumichrast Martin A. | Director / Officer | A-Award | A | Common stock | 39,982 | 0.00 | — | 1,853,254 | — | ↗ |
| 2022-02-28 | Coffman Raymond Scott | Director / Officer / 10% Owner | A-Award | A | Common stock | 291,646 | 0.00 | — | 16,290,653 | — | ↗ |
| 2022-01-27 | Whitford Bradley Nelson | Officer | — | D | Stock Options (Right to Buy) | 334 | 45.00 | 15.0K | 0 | — | ↗ |
| 2022-01-01 | Sumichrast Martin A. | Director / Officer | M-Exempt | A | Common Stock | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2021-12-28 | Sumichrast Martin A. | Director / Officer | A-Award | A | Common stock | 42,004 | 0.00 | — | 1,563,272 | — | ↗ |
| 2021-12-28 | Coffman Raymond Scott | Director / Officer / 10% Owner | A-Award | A | Common stock | 306,397 | 0.00 | — | 15,999,007 | — | ↗ |
| 2021-10-01 | Kennedy Thomas Ronan | Officer | M-Exempt | D | Restricted Stock Unites | 16,667 | 0.00 | — | 0 | — | ↗ |
| 2021-09-28 | Wiesehan John J III | Officer | J-Other | D | Common Stock | 161,550 | 0.00 | — | 0 | — | ↗ |
| 2021-08-24 | Kennedy Thomas Ronan | Officer | P-Purchase | A | Common stock | 7,400 | 2.04 | 15.1K | 7,400 | — | ↗ |
| 2021-08-18 | Wiesehan John J III | Officer | P-Purchase | A | 8% Series A Cumulative Convertible Preferred Stock | 2,000 | 6.00 | 12.0K | 2,000 | — | ↗ |
| 2021-08-16 | Sumichrast Martin A. | Director / Officer | A-Award | A | Common stock | 45,295 | 0.00 | — | 1,521,244 | — | ↗ |
| 2021-08-16 | Coffman Raymond Scott | Director / Officer / 10% Owner | A-Award | A | Common Stock | 330,400 | 0.00 | — | 15,690,432 | — | ↗ |
| 2021-07-22 | Wiesehan John J III | Officer | P-Purchase | A | Common Stock | 161,550 | 2,000,000.00 | 323.10B | 161,550 | — | ↗ |
| 2021-05-14 | Sumichrast Martin A. | Director / Officer | A-Award | A | Common stock | 50,605 | 0.00 | — | 1,475,949 | — | ↗ |
| 2021-05-14 | Coffman Raymond Scott | Director / Officer / 10% Owner | A-Award | A | Common stock | 369,136 | 0.00 | — | 15,360,032 | — | ↗ |
| 2021-04-19 | Sumichrast Martin A. | Director / Officer | A-Award | A | Stock option | 250,000 | 3.39 | 847.5K | 250,000 | — | ↗ |
| 2021-03-12 | Stephen Scott G. | Director | A-Award | A | stock option | 30,000 | 4.40 | 132.0K | 30,000 | — | ↗ |
| 2021-03-12 | Sellers Bakari T. | Director | A-Award | A | Common stock | 5,000 | 0.00 | — | 7,531 | — | ↗ |
| 2021-03-12 | Raines William F III | Director | J-Other | D | Common stock | 693,000 | 0.00 | — | 3,775,924 | — | ↗ |
| 2021-03-12 | Ghiloni Peter J. | Director | A-Award | A | Restricted stock award | 1,250 | 0.00 | — | 1,250 | — | ↗ |
| 2021-03-12 | Farar Sim | Director | A-Award | A | restricted stock award | 1,250 | 0.00 | — | 1,250 | — | ↗ |
| 2021-03-11 | Sumichrast Martin A. | Director / Officer | S-Sale | D | Common stock | 65,493 | 3.93 | 257.6K | 1,425,344 | — | ↗ |
| 2021-03-10 | Sumichrast Martin A. | Director / Officer | S-Sale | D | Common stock | 59,507 | 4.04 | 240.1K | 1,490,837 | — | ↗ |
| 2021-03-08 | Sumichrast Martin A. | Director / Officer | A-Award | A | Common stock | 301,343 | 0.00 | — | 1,550,344 | — | ↗ |
| 2021-03-08 | Coffman Raymond Scott | Director / Officer / 10% Owner | A-Award | A | Common Stock | 2,196,126 | 0.00 | — | 14,990,896 | — | ↗ |
| 2021-03-02 | Raines William F III | Director | S-Sale | D | Common Stock | 20,000 | 4.04 | 80.7K | 1,342 | — | ↗ |
| 2021-02-22 | Coffman Raymond Scott | Director / Officer / 10% Owner | S-Sale | D | Common stock | 122,000 | 4.25 | 518.8K | 0 | — | ↗ |
| 2021-02-19 | Sumichrast Martin A. | Director / Officer | S-Sale | D | Common Stock | 240,035 | 4.42 | 1.06M | 0 | — | ↗ |
| 2021-02-19 | Coffman Raymond Scott | Director / Officer / 10% Owner | S-Sale | D | Common stock | 3,000 | 4.28 | 12.8K | 122,000 | — | ↗ |
| 2021-02-18 | Sumichrast Martin A. | Director / Officer | S-Sale | D | Common stock | 113,104 | 4.43 | 500.8K | 240,035 | — | ↗ |
| 2021-02-17 | Sumichrast Martin A. | Director / Officer | S-Sale | D | Common Stock | 42,461 | 4.54 | 192.8K | 353,139 | — | ↗ |
| 2020-12-20 | Raines William F III | Director | J-Other | D | Common Stock | 2,187,500 | 0.00 | — | 4,488,924 | — | ↗ |
| 2020-10-01 | Kennedy Thomas Ronan | Officer | A-Award | A | Restricted stock award | 16,666 | 0.00 | — | 16,666 | — | ↗ |
| 2020-10-01 | Elliott Mark S | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-09-16 | Elliott Mark S | Officer | A-Award | A | Stock Option | 300,000 | 2.60 | 780.0K | 300,000 | — | ↗ |
| 2020-08-14 | Sellers Bakari T. | Director | S-Sale | D | Common Stock | 10,000 | 3.43 | 34.3K | 2,531 | — | ↗ |
| 2020-05-27 | Stephen Scott G. | Director | A-Award | A | Stock Options | 20,000 | 1.57 | 31.4K | 20,000 | — | ↗ |
| 2020-05-27 | Sellers Bakari T. | Director | A-Award | A | Stock Option | 20,000 | 1.57 | 31.4K | 20,000 | — | ↗ |
| 2020-05-27 | Raines William F III | Director | A-Award | A | Stock Option | 20,000 | 1.57 | 31.4K | 20,000 | — | ↗ |
| 2020-05-27 | Ghiloni Peter J. | Director | A-Award | A | Stock Options | 20,000 | 1.57 | 31.4K | 20,000 | — | ↗ |
| 2020-04-23 | Shriver Anthony Kennedy | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-04-23 | SIEGEL SEYMOUR | Director | J-Other | D | Common Stock | 6,562,500 | 0.00 | — | 2,531 | — | ↗ |
| 2020-04-23 | Raines William F III | Director | J-Other | A | Common Stock | 6,562,500 | 0.00 | — | 6,676,424 | — | ↗ |
| 2020-04-23 | Morris Gregory C | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-03-09 | Ghiloni Peter J. | Director | P-Purchase | A | Common stock | 25,000 | 0.75 | 18.7K | 300,000 | — | ↗ |
| 2020-02-27 | Sumichrast Martin A. | Director / Officer | J-Other | A | Common Stock | 461,501 | 0.00 | — | 1,644,601 | — | ↗ |
| 2020-02-27 | Dunayer Caryn Nicole | Officer | J-Other | A | Common stock | 256,390 | 0.00 | — | 993,890 | — | ↗ |
| 2020-02-27 | Coffman Raymond Scott | Director / Officer / 10% Owner | J-Other | A | Common Stock | 3,366,395 | 0.00 | — | 12,919,770 | — | ↗ |
| 2020-02-26 | Sumichrast Martin A. | Director / Officer | J-Other | A | Earnout Rights | 910,999 | 0.00 | — | 910,999 | — | ↗ |
| 2020-02-26 | Dunayer Caryn Nicole | Officer | J-Other | A | Common stock | 437,500 | 0.00 | — | 737,500 | — | ↗ |
| 2020-02-26 | Coffman Raymond Scott | Director / Officer / 10% Owner | J-Other | A | Common Stock | 5,744,375 | 0.00 | — | 9,553,375 | — | ↗ |
| 2020-01-27 | Elliott Mark S | Officer | P-Purchase | A | Common stock | 5,000 | 1.06 | 5.3K | 51,680 | — | ↗ |
| 2020-01-14 | Sumichrast Martin A. | Director / Officer | P-Purchase | A | Common Stock | 125,000 | 1.00 | 125.0K | 395,600 | — | ↗ |
| 2020-01-14 | Stephen Scott G. | Director | P-Purchase | A | Common Stock | 20,000 | 1.00 | 20.0K | 41,052 | — | ↗ |
| 2020-01-14 | Sellers Bakari T. | Director | P-Purchase | A | common stock | 10,000 | 1.00 | 10.0K | 12,531 | — | ↗ |
| 2020-01-14 | Raines William F III | Director | P-Purchase | A | Common Stock | 20,000 | 1.00 | 20.0K | 113,924 | — | ↗ |
| 2020-01-14 | Morris Gregory C | Director | P-Purchase | A | Common Stock | 15,000 | 1.00 | 15.0K | 17,531 | — | ↗ |
| 2020-01-14 | Ghiloni Peter J. | Director | P-Purchase | A | Common Stock | 125,000 | 1.00 | 125.0K | 275,000 | — | ↗ |
| 2020-01-14 | Elliott Mark S | Officer | P-Purchase | A | Common Stock | 15,000 | 1.00 | 15.0K | 46,680 | — | ↗ |
| 2020-01-14 | Coffman Raymond Scott | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 125,000 | 1.00 | 125.0K | 12,559,000 | — | ↗ |
| 2019-12-20 | SIEGEL SEYMOUR | Director | J-Other | D | Common Stock | 2,187,500 | 0.00 | — | 6,562,500 | — | ↗ |
| 2019-12-11 | Sumichrast Martin A. | Director / Officer | A-Award | A | stock option | 46,667 | 3.15 | 147.0K | 46,667 | — | ↗ |
| 2019-12-11 | Coffman Raymond Scott | Director / Officer / 10% Owner | A-Award | A | stock option | 46,667 | 3.15 | 147.0K | 46,667 | — | ↗ |
| 2019-08-14 | Raines William F III | Director | A-Award | A | Stock option | 20,000 | 5.41 | 108.2K | 20,000 | — | ↗ |
| 2019-07-01 | Dunayer Caryn Nicole | Officer | — | I | Common Stock | 0 | 0.00 | — | 300,000 | — | ↗ |
| 2019-05-09 | Stephen Scott G. | Director | A-Award | A | Stock Option | 20,000 | 5.41 | 108.2K | 20,000 | — | ↗ |
| 2019-05-09 | Shriver Anthony Kennedy | Director | A-Award | A | Stock Option | 20,000 | 5.41 | 108.2K | 20,000 | — | ↗ |
| 2019-05-09 | Sellers Bakari T. | Director | A-Award | A | Stock Option | 20,000 | 5.41 | 108.2K | 20,000 | — | ↗ |
| 2019-05-09 | SIEGEL SEYMOUR | Director | A-Award | A | Stock Option | 20,000 | 5.41 | 108.2K | 20,000 | — | ↗ |
| 2019-05-09 | Morris Gregory C | Director | A-Award | A | Stock Option | 20,000 | 5.41 | 108.2K | 20,000 | — | ↗ |
| 2019-05-09 | Ghiloni Peter J. | Director | A-Award | A | Stock Options | 20,000 | 5.41 | 108.2K | 20,000 | — | ↗ |
| 2019-04-22 | Stephen Scott G. | Director | — | I | Common stock | 0 | 0.00 | — | 21,052 | — | ↗ |
| 2019-04-22 | SIEGEL SEYMOUR | Director | C-Conversion | A | Common Stock | 8,750,000 | 0.00 | — | 8,750,000 | — | ↗ |
| 2019-04-22 | Raines William F III | Director | — | I | common stock | 0 | 0.00 | — | 92,582 | — | ↗ |
| 2019-04-22 | Ghiloni Peter J. | Director | — | D | Common stock | 0 | 0.00 | — | 150,000 | — | ↗ |
| 2019-04-22 | Coffman Raymond Scott | Director | C-Conversion | A | common stock | 3,684,000 | 0.00 | — | 3,684,000 | — | ↗ |
| 2019-04-16 | Sterling Erik | 10% Owner | S-Sale | D | Common Stock, par value $0.001 per share | 583,000 | 4.00 | 2.33M | 0 | — | ↗ |
| 2019-03-07 | Sumichrast Martin A. | Director / Officer | S-Sale | D | Common Stock | 325,834 | 4.00 | 1.30M | 270,600 | — | ↗ |
| 2019-02-20 | Sumichrast Martin A. | Director / Officer | S-Sale | D | Common stock | 150,000 | 4.00 | 600.0K | 596,434 | — | ↗ |
| 2019-02-06 | Sterling Erik | 10% Owner | G-Gift | D | Common Stock, par value $0.001 per share | 15,000 | 0.00 | — | 25,000 | — | ↗ |
| 2018-12-20 | Coffman Raymond Scott | Director | — | I | Contract Right | 8,750,000 | 0.00 | — | 0 | — | ↗ |
| 2018-08-16 | Sterling Erik | Director | A-Award | A | Options grant | 7,000 | 3.34 | 23.4K | 7,000 | — | ↗ |
| 2018-08-16 | Shriver Anthony Kennedy | Director | A-Award | A | Options grant | 7,000 | 3.34 | 23.4K | 7,000 | — | ↗ |
| 2018-08-16 | Sellers Bakari T. | Director | A-Award | A | Options grant | 7,000 | 3.34 | 23.4K | 7,000 | — | ↗ |
| 2018-08-16 | SIEGEL SEYMOUR | Director | A-Award | A | Options grant | 7,000 | 3.34 | 23.4K | 7,000 | — | ↗ |
| 2018-08-16 | Morris Gregory C | Director | A-Award | A | Options grant | 7,000 | 3.34 | 23.4K | 7,000 | — | ↗ |
| 2018-07-01 | Sumichrast Martin A. | Director / Officer | J-Other | D | Common Stock | 150,000 | 4.30 | 645.0K | 746,434 | — | ↗ |
| 2018-05-29 | Elliott Mark S | Officer | A-Award | A | Options grant | 0 | 4.78 | — | 75,000 | — | ↗ |
| 2018-01-01 | Sumichrast Martin A. | Director / Officer | M-Exempt | D | restricted stock grant | 150,000 | 0.00 | — | 0 | — | ↗ |
| 2018-01-01 | Sterling Erik | Director / 10% Owner | — | D | Restricted stock award | 40,000 | 0.00 | — | 0 | — | ↗ |
| 2018-01-01 | Shriver Anthony Kennedy | Director | — | D | Restricted stock award | 40,000 | 0.00 | — | 0 | — | ↗ |
| 2018-01-01 | Elliott Mark S | Officer | — | D | Stock Option | 100,000 | 7.50 | 750.0K | 0 | — | ↗ |
| 2017-11-16 | Sumichrast Martin A. | Director / Officer | — | I | Common stock, par value $0.001 per share | 0 | 0.00 | — | 325,834 | — | ↗ |
| 2017-11-16 | Sterling Erik | Director / 10% Owner | — | I | Common stock, par value $0.001 per share | 0 | 0.00 | — | 866,000 | — | ↗ |
| 2017-11-16 | Shriver Anthony Kennedy | Director | — | I | Common stock, par value $0.001 per share | 0 | 0.00 | — | 50,000 | — | ↗ |
| 2017-11-16 | Sellers Bakari T. | Director | — | D | Common stock, par value $0.001 per share | 0 | 0.00 | — | 2,531 | — | ↗ |
| 2017-11-16 | SIEGEL SEYMOUR | Director | — | D | Common stock, par value $0.001 per share | 0 | 0.00 | — | 2,531 | — | ↗ |
| 2017-11-16 | Morris Gregory C | Director | — | D | Common stock, par value $0.001 per share | 0 | 0.00 | — | 2,531 | — | ↗ |
| 2017-11-16 | Elliott Mark S | Officer | — | D | Common stock, par value $0.001 per share | 0 | 0.00 | — | 30,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-51.5K
Shares Outstanding
10.50M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Ronan Kennedy, CEO and CFO | 275.0K | — | — | — | — | — | 275.0K | 0.00% | ↗ |
| 2 | 2024 | Bradley Whitford Chief Accounting Officer Kevin MacDermott | 181.4K | — | — | — | — | — | 181.4K | 0.00% | ↗ |
| 3 | 2023 | Ronan Kennedy, CEO and CFO | 275.0K | — | — | — | — | — | 275.0K | 0.00% | ↗ |
| 4 | 2023 | Bradley Whitford Chief Accounting Officer Kevin MacDermott | 185.8K | — | 3.5K | 2.2K | — | — | 191.4K | 2.97% | ↗ |
| 5 | 2022 | Martin Sumichrast, Co-CEO | 300.6K | — | 172.0K | — | — | 133.3K | 605.9K | 28.39% | ↗ |
| 6 | 2022 | Ronan Kennedy, CFO and COO | 276.0K | 100.0K | 49.0K | 132.8K | — | — | 557.7K | 32.59% | ↗ |
| 7 | 2022 | Kevin MacDermott, President | 109.9K | — | 90.0K | 291.6K | — | — | 491.5K | 77.64% | ↗ |
| 8 | 2022 | Scott Coffman, Co-CEO | 259.0K | — | — | — | — | — | 259.0K | 0.00% | ↗ |
| 9 | 2021 | Martin Sumichrast, Co-CEO | 328.7K | 250.0K | 2.52M | 1.69M | — | 11.5K | 4.80M | 87.71% | ↗ |
| 10 | 2021 | Ronan Kennedy, CFO and COO | 247.1K | — | 100.0K | 372.7K | — | — | 719.8K | 65.67% | ↗ |
| 11 | 2021 | Scott Coffman, Co-CEO | 313.3K | 250.0K | — | — | — | — | 563.3K | 0.00% | ↗ |
| 12 | 2020 | Martin A. Sumichrast co-CEO | 281.0K | 160.0K | 286.2K | — | — | — | 727.2K | 39.35% | ↗ |
| 13 | 2020 | Mark S. Elliott CFO and COO | 210.0K | 62.5K | 273.6K | — | — | — | 546.1K | 50.10% | ↗ |
| 14 | 2020 | R. Scott Coffman co-CEO | 186.9K | — | 286.2K | — | — | — | 473.1K | 60.49% | ↗ |
| 15 | 2019 | Martin A. Sumichrast co-CEO | 279.1K | 225.0K | — | — | — | — | 504.1K | 0.00% | ↗ |
| 16 | 2019 | Mark S. Elliott CFO and COO | 207.3K | 112.5K | — | — | — | — | 319.8K | 0.00% | ↗ |
| 17 | 2019 | Caryn Dunayer | 101.2K | 40.0K | — | — | — | — | 141.2K | 0.00% | ↗ |
| 18 | 2019 | R. Scott Coffman co-CEO | 132.2K | — | — | — | — | — | 132.2K | 0.00% | ↗ |
| 19 | 2019 | R. Scott Coffman co-CEO | 132.2K | — | — | — | — | — | 132.2K | 0.00% | ↗ |
| 20 | 2018 | Mark S. Elliott Chief Financial Officer and Chief Operating Officer | 165.0K | 100.0K | — | 519.0K | — | — | 784.0K | 66.20% | ↗ |
| 21 | 2018 | Mark S. Elliott CFO and COO | 165.0K | 100.0K | — | 519.0K | — | — | 784.0K | 66.20% | ↗ |
| 22 | 2018 | Martin A. Sumichrast Chief Executive Officer | 232.5K | 240.0K | — | — | — | — | 472.5K | 0.00% | ↗ |
| 23 | 2018 | Martin A. Sumichrast co-CEO | 232.5K | 240.0K | — | — | — | — | 472.5K | 0.00% | ↗ |
| 24 | 2017 | Martin A. Sumichrast Chief Executive Officer | 90.0K | — | 127.5K | — | — | — | 217.5K | 58.62% | ↗ |
| 25 | 2017 | Mark S. Elliott Chief Financial Officer and Chief Operating Officer | 90.0K | — | 17.0K | 35.0K | — | 18.0K | 160.0K | 32.50% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| T. Ronan Kennedy | Chief Executive Officer, Chief Financial Officer, Principal Executive Officer & Director | 300.0K | male |
| Bradley Whitford | Chief Accounting Officer, Treasurer & Secretary | 207.3K | male |
| Sibyl Swift | CSO, Vice President of Regulatory Affairs & Director | 113.6K | — |
| Lance Blundell | General Counsel | — | male |
| Shannon Charles | Chief Marketing Officer | — | female |
| Zeb Booker | Chief Technology Officer | — | male |
| David Johnson | Senior Vice President of Business Development | — | male |
| Francisco Mangual | Senior Vice President of Sales | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for YCBD
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
